Condition
Hypercholerolemia
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07676214Not Yet Recruiting
Faisalabad Initiative of Research and Management of NCDs
NCT07581028Phase 1Not Yet RecruitingPrimary
Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers
NCT06729905Not ApplicableCompleted
Study of the Effects of Yerba Mate on Cardiometabolic Health
NCT00157911Phase 3CompletedPrimary
A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)
Showing all 4 trials